sdz wag-994 has been researched along with n(6)-cyclopentyladenosine in 1 studies
| Studies (sdz wag-994) | Trials (sdz wag-994) | Recent Studies (post-2010) (sdz wag-994) | Studies (n(6)-cyclopentyladenosine) | Trials (n(6)-cyclopentyladenosine) | Recent Studies (post-2010) (n(6)-cyclopentyladenosine) |
|---|---|---|---|---|---|
| 16 | 3 | 3 | 605 | 0 | 62 |
| Protein | Taxonomy | sdz wag-994 (IC50) | n(6)-cyclopentyladenosine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.2256 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 1.16 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0027 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 1.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, AJ; Judge, ME; Knutsen, LJ; Lau, J; Petersen, H; Shalmi, M; Sheardown, MJ; Thomsen, C; Weis, JU | 1 |
1 other study(ies) available for sdz wag-994 and n(6)-cyclopentyladenosine
| Article | Year |
|---|---|
N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
Topics: Adenosine; Animals; Blood Pressure; Brain; Brain Ischemia; Cardiovascular System; Cell Line; Gerbillinae; Guinea Pigs; Hypotension; Mice; Mice, Inbred Strains; Neuroprotective Agents; Protein Binding; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred Strains | 1999 |